Q1 Earnings Estimate for Cresco Labs Issued By Roth Capital

Cresco Labs Inc. (OTCMKTS:CRLBF) – Stock analysts at Roth Capital issued their Q1 2025 earnings per share (EPS) estimates for Cresco Labs in a research report issued on Thursday, March 13th. Roth Capital analyst W. Kirk expects that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Roth Capital also issued estimates for Cresco Labs’ Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at ($0.08) EPS and FY2026 earnings at ($0.04) EPS.

Cresco Labs (OTCMKTS:CRLBF) last issued its quarterly earnings data on Friday, March 14th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The company had revenue of $176.00 million during the quarter, compared to analyst estimates of $172.10 million.

Separately, Atb Cap Markets lowered Cresco Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th. Three analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $3.00.

Cresco Labs Stock Up 6.6 %

Shares of OTCMKTS CRLBF opened at $0.75 on Monday. Cresco Labs has a 12 month low of $0.70 and a 12 month high of $2.60. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. The firm has a market capitalization of $364.25 million, a price-to-earnings ratio of -3.73 and a beta of 1.79. The business has a 50-day moving average of $0.89 and a 200-day moving average of $1.20.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.